![](https://entrepreneurs.utoronto.ca/wp-content/uploads/2021/08/Notch_Alumni.jpg)
Notch Therapeutics
NotchTX is a platform technology that uses stem cells to produce progenitor T-cells that can be manufactured at scale, will potentially be less toxic, longer lasting, and will substitute mature T-cells as a starting cell source for current and future T-cell therapies. ProT Therapeutics’ technology includes proprietary, fully-defined, scalable, serum-free and feeder-free method to generate…